SlideShare a Scribd company logo
1 of 2
Download to read offline
 
  
www.oncologyltd.co.uk www.oncologyltd.co.uk www.oncologyltd.co.uk           
PHARMACEUTICAL
EXPERIENCE
Oncology Limited has a proven
track record working for a variety
of major oncology pharmaceutical
companies, both in permanent
employment positions and on a
consultancy basis.
BUSINESS
PERSPECTIVE
Since 2008 Oncology Ltd has worked
with major oncology companies,
providing strategic sales and
marketing support for large oncology
products including: Nplate, Evoltra ,
Fludarabine, MabCampath, Tyverb,
Herceptin, Avastin, Xeloda and
MabThera.
CLINICAL
PERSPECTIVE
As well as sound oncology marketing
insight developed during 20 years in the
pharmaceutical industry, Oncology Ltd
can also provide clinical input from an
oncology and haematology nurse
perspective, utilising experience gained
working as an oncology nurse at the
Royal Marsden Hospital.
  
Summary
 
  
www.oncologyltd.co.uk www.oncologyltd.co.uk www.oncologyltd.co.uk           
PATIENT
PERSPECTIVE
Success in oncology will only come if
the end result improves outcomes for
patients. Whilst progression free
survival and overall survival are obvious
critical end-points in determining a
cancer products value, understanding
what a treatment actual means for
patients, needs to be a vital part of any
product development plan. Patient
access restrictions often limit the
pharmaceutical industry’s ability to do
this.
ONCOLOGYLIMITED
STRATEGIC SALES & MARKETING SUPPORT
Oncology Limited can provide insight
from three critical perspectives in
cancer. This unique combination of
experience provides an extremely
valuable understanding of cancer,
which includes its physical and
psychological impact on patients and
their care-givers and the challenges of
product marketing in this complex
disease area.
For more information please
contact
BRUCE GILLIGAN
brucegilligan@oncologyltd.co.uk
Mobile: +44(0)7909 974416
PA
TIEN
T
PERS
PECT
IVE
ONCOLOGY LIMITED
STRATEGIC SALES & MARKETING SUPPORT
The logo says it all !
If you could tap into extensive
oncology pharmaceutical marketing
expertise and at the same time benefit
from an oncology nurse and patient
perspective on cancer, imagine how
insightful your oncology business
strategy could be?

More Related Content

Viewers also liked

강서오피, 인천오피,논현오피@(다솜넷)동탄오피
강서오피, 인천오피,논현오피@(다솜넷)동탄오피강서오피, 인천오피,논현오피@(다솜넷)동탄오피
강서오피, 인천오피,논현오피@(다솜넷)동탄오피dasom010
 
부평오피, 마포오피,평촌오피@(다솜넷)천안오피
부평오피, 마포오피,평촌오피@(다솜넷)천안오피부평오피, 마포오피,평촌오피@(다솜넷)천안오피
부평오피, 마포오피,평촌오피@(다솜넷)천안오피dasom010
 
평촌오피, 부평오피,선릉오피@(다솜넷)역삼역오피
평촌오피, 부평오피,선릉오피@(다솜넷)역삼역오피평촌오피, 부평오피,선릉오피@(다솜넷)역삼역오피
평촌오피, 부평오피,선릉오피@(다솜넷)역삼역오피dasom010
 
Ah mourir de rire
Ah mourir de rireAh mourir de rire
Ah mourir de rirepapybrico
 
강서오피&인천오피,강남오피@<다솜넷>일산오피
강서오피&인천오피,강남오피@<다솜넷>일산오피강서오피&인천오피,강남오피@<다솜넷>일산오피
강서오피&인천오피,강남오피@<다솜넷>일산오피dasom010
 
강서오피, 인천오피,역삼오피@(다솜넷)부천오피
강서오피, 인천오피,역삼오피@(다솜넷)부천오피강서오피, 인천오피,역삼오피@(다솜넷)부천오피
강서오피, 인천오피,역삼오피@(다솜넷)부천오피dasom010
 
평촌오피, 야탑오피,천안오피@(다솜넷)수원오피
평촌오피, 야탑오피,천안오피@(다솜넷)수원오피평촌오피, 야탑오피,천안오피@(다솜넷)수원오피
평촌오피, 야탑오피,천안오피@(다솜넷)수원오피dasom013
 
청주오피, 분당오피,부평오피@(다솜넷)일산오피
청주오피, 분당오피,부평오피@(다솜넷)일산오피청주오피, 분당오피,부평오피@(다솜넷)일산오피
청주오피, 분당오피,부평오피@(다솜넷)일산오피dasom013
 

Viewers also liked (8)

강서오피, 인천오피,논현오피@(다솜넷)동탄오피
강서오피, 인천오피,논현오피@(다솜넷)동탄오피강서오피, 인천오피,논현오피@(다솜넷)동탄오피
강서오피, 인천오피,논현오피@(다솜넷)동탄오피
 
부평오피, 마포오피,평촌오피@(다솜넷)천안오피
부평오피, 마포오피,평촌오피@(다솜넷)천안오피부평오피, 마포오피,평촌오피@(다솜넷)천안오피
부평오피, 마포오피,평촌오피@(다솜넷)천안오피
 
평촌오피, 부평오피,선릉오피@(다솜넷)역삼역오피
평촌오피, 부평오피,선릉오피@(다솜넷)역삼역오피평촌오피, 부평오피,선릉오피@(다솜넷)역삼역오피
평촌오피, 부평오피,선릉오피@(다솜넷)역삼역오피
 
Ah mourir de rire
Ah mourir de rireAh mourir de rire
Ah mourir de rire
 
강서오피&인천오피,강남오피@<다솜넷>일산오피
강서오피&인천오피,강남오피@<다솜넷>일산오피강서오피&인천오피,강남오피@<다솜넷>일산오피
강서오피&인천오피,강남오피@<다솜넷>일산오피
 
강서오피, 인천오피,역삼오피@(다솜넷)부천오피
강서오피, 인천오피,역삼오피@(다솜넷)부천오피강서오피, 인천오피,역삼오피@(다솜넷)부천오피
강서오피, 인천오피,역삼오피@(다솜넷)부천오피
 
평촌오피, 야탑오피,천안오피@(다솜넷)수원오피
평촌오피, 야탑오피,천안오피@(다솜넷)수원오피평촌오피, 야탑오피,천안오피@(다솜넷)수원오피
평촌오피, 야탑오피,천안오피@(다솜넷)수원오피
 
청주오피, 분당오피,부평오피@(다솜넷)일산오피
청주오피, 분당오피,부평오피@(다솜넷)일산오피청주오피, 분당오피,부평오피@(다솜넷)일산오피
청주오피, 분당오피,부평오피@(다솜넷)일산오피
 

Similar to Brochure Print copy

amgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportamgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportfinance18
 
amgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportamgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportfinance18
 
amgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportamgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportfinance18
 
amgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportamgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportfinance18
 
Clinical Trial Supply
Clinical Trial SupplyClinical Trial Supply
Clinical Trial SupplyAbdul Jamad
 
Baxalta_2015_AnnualReport_FINAL
Baxalta_2015_AnnualReport_FINALBaxalta_2015_AnnualReport_FINAL
Baxalta_2015_AnnualReport_FINALNatacha Gassenbach
 
Peter Cormack CV Sept 2015
Peter Cormack CV Sept 2015Peter Cormack CV Sept 2015
Peter Cormack CV Sept 2015Peter Cormack
 
John Hickey CV 072216
John Hickey CV 072216John Hickey CV 072216
John Hickey CV 072216John Hickey
 
Cancer detection therapy
Cancer detection therapyCancer detection therapy
Cancer detection therapyWalt Whitman
 
European pharmacovigilance and_clinical_trials_2016
European pharmacovigilance and_clinical_trials_2016European pharmacovigilance and_clinical_trials_2016
European pharmacovigilance and_clinical_trials_2016Fazmina Fajju
 
European pharmacovigilance and clinical trials 2016
European pharmacovigilance and clinical trials 2016European pharmacovigilance and clinical trials 2016
European pharmacovigilance and clinical trials 2016Harris John
 
Duphat brochure 2020
Duphat brochure 2020Duphat brochure 2020
Duphat brochure 2020AnkitNigam38
 
CHLA Pediatric Health Investment Opportunities_Sept 16
CHLA Pediatric Health Investment Opportunities_Sept 16CHLA Pediatric Health Investment Opportunities_Sept 16
CHLA Pediatric Health Investment Opportunities_Sept 16Jessica Rousset
 
ANGLE Annual Report 2013
ANGLE Annual Report 2013ANGLE Annual Report 2013
ANGLE Annual Report 2013ANGLE plc
 

Similar to Brochure Print copy (20)

amgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportamgen Investors_2006_Annual Report
amgen Investors_2006_Annual Report
 
amgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportamgen Investors_2006_Annual Report
amgen Investors_2006_Annual Report
 
amgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportamgen Investors_2006_Annual Report
amgen Investors_2006_Annual Report
 
amgen Investors_2006_Annual Report
amgen Investors_2006_Annual Reportamgen Investors_2006_Annual Report
amgen Investors_2006_Annual Report
 
Resume NBSA
Resume NBSAResume NBSA
Resume NBSA
 
Platform Update
Platform UpdatePlatform Update
Platform Update
 
CTSC 16
CTSC 16CTSC 16
CTSC 16
 
Clinical Trial Supply
Clinical Trial SupplyClinical Trial Supply
Clinical Trial Supply
 
BioKinetic Profile.docx
BioKinetic Profile.docxBioKinetic Profile.docx
BioKinetic Profile.docx
 
Baxalta_2015_AnnualReport_FINAL
Baxalta_2015_AnnualReport_FINALBaxalta_2015_AnnualReport_FINAL
Baxalta_2015_AnnualReport_FINAL
 
Peter Cormack CV Sept 2015
Peter Cormack CV Sept 2015Peter Cormack CV Sept 2015
Peter Cormack CV Sept 2015
 
John Hickey CV 072216
John Hickey CV 072216John Hickey CV 072216
John Hickey CV 072216
 
Jennifer Y
Jennifer YJennifer Y
Jennifer Y
 
Globe Healthcare ppt.pptx
Globe Healthcare ppt.pptxGlobe Healthcare ppt.pptx
Globe Healthcare ppt.pptx
 
Cancer detection therapy
Cancer detection therapyCancer detection therapy
Cancer detection therapy
 
European pharmacovigilance and_clinical_trials_2016
European pharmacovigilance and_clinical_trials_2016European pharmacovigilance and_clinical_trials_2016
European pharmacovigilance and_clinical_trials_2016
 
European pharmacovigilance and clinical trials 2016
European pharmacovigilance and clinical trials 2016European pharmacovigilance and clinical trials 2016
European pharmacovigilance and clinical trials 2016
 
Duphat brochure 2020
Duphat brochure 2020Duphat brochure 2020
Duphat brochure 2020
 
CHLA Pediatric Health Investment Opportunities_Sept 16
CHLA Pediatric Health Investment Opportunities_Sept 16CHLA Pediatric Health Investment Opportunities_Sept 16
CHLA Pediatric Health Investment Opportunities_Sept 16
 
ANGLE Annual Report 2013
ANGLE Annual Report 2013ANGLE Annual Report 2013
ANGLE Annual Report 2013
 

Brochure Print copy

  • 1.     www.oncologyltd.co.uk www.oncologyltd.co.uk www.oncologyltd.co.uk         PHARMACEUTICAL EXPERIENCE Oncology Limited has a proven track record working for a variety of major oncology pharmaceutical companies, both in permanent employment positions and on a consultancy basis. BUSINESS PERSPECTIVE Since 2008 Oncology Ltd has worked with major oncology companies, providing strategic sales and marketing support for large oncology products including: Nplate, Evoltra , Fludarabine, MabCampath, Tyverb, Herceptin, Avastin, Xeloda and MabThera. CLINICAL PERSPECTIVE As well as sound oncology marketing insight developed during 20 years in the pharmaceutical industry, Oncology Ltd can also provide clinical input from an oncology and haematology nurse perspective, utilising experience gained working as an oncology nurse at the Royal Marsden Hospital.   Summary
  • 2.     www.oncologyltd.co.uk www.oncologyltd.co.uk www.oncologyltd.co.uk         PATIENT PERSPECTIVE Success in oncology will only come if the end result improves outcomes for patients. Whilst progression free survival and overall survival are obvious critical end-points in determining a cancer products value, understanding what a treatment actual means for patients, needs to be a vital part of any product development plan. Patient access restrictions often limit the pharmaceutical industry’s ability to do this. ONCOLOGYLIMITED STRATEGIC SALES & MARKETING SUPPORT Oncology Limited can provide insight from three critical perspectives in cancer. This unique combination of experience provides an extremely valuable understanding of cancer, which includes its physical and psychological impact on patients and their care-givers and the challenges of product marketing in this complex disease area. For more information please contact BRUCE GILLIGAN brucegilligan@oncologyltd.co.uk Mobile: +44(0)7909 974416 PA TIEN T PERS PECT IVE ONCOLOGY LIMITED STRATEGIC SALES & MARKETING SUPPORT The logo says it all ! If you could tap into extensive oncology pharmaceutical marketing expertise and at the same time benefit from an oncology nurse and patient perspective on cancer, imagine how insightful your oncology business strategy could be?